Britain approves GSK-Vir antibody-based COVID-19 treatment
(Reuters) – Britain’s drug regulator on Thursday approved GSK and Vir Biotechnology’s antibody based COVID-19 treatment, Xevudy, for people with mild-to-moderate COVID-19 who are at...
Investment News, Crypto, Markets & Finance
(Reuters) – Britain’s drug regulator on Thursday approved GSK and Vir Biotechnology’s antibody based COVID-19 treatment, Xevudy, for people with mild-to-moderate COVID-19 who are at...
LONDON (Reuters) -The growth of British house prices accelerated last month and the market was holding up despite the end of pandemic emergency support measures...
LONDON (Reuters) – The volume of Black Friday payment transactions in Britain as of 0900 GMT was up 5.4% versus 2019 and up 21.4% on...
Investing.com – The FTSE 100 edged higher on Thursday in quiet trade with US markets closed for the Thanksgiving holiday. The hotel names, InterContinental (LON:IHG) and Whitbread (LON:WTB) were...